Venture philanthropy organisation Solve FSHD has announced an investment of $3m in Armatus Bio to support the development of ...

The European Commission (EC) has approved AstraZeneca's Bruton's tyrosine kinase (BTK) inhibitor Calquence (acalabrutinib) ...

The deal builds on an existing research collaboration between Eli Lilly and Alchemab to discover new ALS drugs.

Mergers and acquisitions (M&As) in the biopharmaceutical industry surged 101% in total deal value in the first quarter (Q1) ...

The options are for the freeze-dried version of Bavarian Nordic’s Jynneos, a formulation that allows easier stockpiling.

Bristol Myers Squibb (BMS) plans to invest $40bn in the US over the next five years to bolster its research and manufacturing ...

Developing orphan drugs involves navigating intricate regulatory landscapes, financial risks, and limited clinical data. To ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), once focused on treating diabetes and obesity, are now emerging as ...

As scientists explore treating genetic disorders before birth, the promise of foetal gene therapy is growing—but there are ...

The therapy is intended for individuals suffering from advanced solid tumours with neurotrophic tyrosine receptor kinase fusion genes. Credit: Chay_Tee/Shutterstock. China National Medical Products ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Bavarian Nordic's ...

Teva and Alvotech have announced receipt of the US FDA approval to Selarsdi injection for use as an interchangeable with ...